C-MER Eye Care Holdings Limited

HKSE 3309.HK

C-MER Eye Care Holdings Limited Price to Book Ratio (P/B) on January 14, 2025: 1.30

C-MER Eye Care Holdings Limited Price to Book Ratio (P/B) is 1.30 on January 14, 2025, a -38.82% change year over year. Price to book ratio compares the stock price to the book value per share; above 1 indicates market values company more than its book value.
  • C-MER Eye Care Holdings Limited 52-week high Price to Book Ratio (P/B) is 2.16 on May 17, 2024, which is 66.98% above the current Price to Book Ratio (P/B).
  • C-MER Eye Care Holdings Limited 52-week low Price to Book Ratio (P/B) is 1.22 on January 10, 2025, which is -5.64% below the current Price to Book Ratio (P/B).
  • C-MER Eye Care Holdings Limited average Price to Book Ratio (P/B) for the last 52 weeks is 1.72.
Key data
Date Price to Book Ratio (P/B) Dividend Yield Free Cash Flow Yield Price to Earnings Ratio (P/E)
Market news
Loading...
HKSE: 3309.HK

C-MER Eye Care Holdings Limited

CEO Dr. Shun Chiu Lam J.P.
IPO Date Jan. 15, 2018
Location Hong Kong
Headquarters Central Building
Employees 2,192
Sector Consumer Discretionary
Industries
Description

C-MER Eye Care Holdings Limited, an investment holding company, provides ophthalmic services under the C-MER Dennis Lam brand name in Hong Kong and Mainland China. The company operates eye and surgery centers, and satellite clinics that provide cataract and intraocular lens implant, refractive correction, corneal and external eye disease, glaucoma, vitreo-retinal disease, oculoplastic and orbital disease, and squint and pediatric ophthalmology services. It also sells vision aid and pharmaceutical products, as well as dental services. The company was founded in 2012 and is headquartered in Central, Hong Kong. C-MER Eye Care Holdings Limited is a subsidiary of C-MER Group Limited.

Similar companies

1789.HK

AK Medical Holdings Limited

USD 0.55

1.88%

1548.HK

Genscript Biotech Corporation

USD 1.17

1.53%

1478.HK

Q Technology (Group) Company Limited

USD 0.71

3.74%

StockViz Staff

January 15, 2025

Any question? Send us an email